# Outpatient Holmium LASER Enucleation of the Prostate: Benefit of MOSES(TM) 2.0 Technology

> **NCT05768776** · — · ACTIVE_NOT_RECRUITING · sponsor: **University Hospital, Bordeaux** · enrollment: 200 (estimated)

## Conditions studied

- Benign Prostatic Hypertrophy
- Holmium Laser Enucleation of the Prostate

## Interventions

- **PROCEDURE:** HoLEP patients without MOSES(TM) 2.0 effect (open label)
- **PROCEDURE:** HoLEP patients with MOSES(TM) 2.0 effect (open label)

## Key facts

- **NCT ID:** NCT05768776
- **Lead sponsor:** University Hospital, Bordeaux
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-06-28
- **Primary completion:** 2025-07
- **Final completion:** 2025-07
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2025-06-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05768776

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05768776, "Outpatient Holmium LASER Enucleation of the Prostate: Benefit of MOSES(TM) 2.0 Technology". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT05768776. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*